Cocrystal Pharma
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $144 |
Gross Profit | -33 | -35 | 72 |
EBITDA | -5,415 | -4,123 | -4,464 |
EBIT | -5,448 | -4,158 | -2,764 |
Net Income | -5,343 | -3,956 | -4,464 |
Net Change In Cash | 0 | 0 | 144 |
Free Cash Flow | -3,699 | -4,511 | -2,920 |
Cash | 18,143 | 21,917 | 26,428 |
Basic Shares | 10,174 | 10,174 | 10,174 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $5,427 | $2,014 |
Gross Profit | -15,169 | -241 | -239 | 1,775 |
EBITDA | -19,372 | -38,447 | -13,799 | -9,304 |
EBIT | -17,984 | -38,835 | -14,181 | -9,640 |
Net Income | -17,984 | -38,845 | -14,189 | -9,656 |
Net Change In Cash | 0 | 0 | 5,427 | 2,014 |
Cost of Revenue | 25,592 | |||
Free Cash Flow | -14,784 | -21,509 | -12,771 | -10,070 |
Cash | 26,353 | 37,144 | 58,705 | 33,010 |
Basic Shares | 9,651 | 8,143 | 88,368 | 55,217 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.49 |
2024-06-30 | -$0.53 |
2024-03-31 | -$0.39 |
2023-12-31 | -$0.44 |
